Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, will expedite its path to market.Continue ReadingCategory: Cancer, Illnesses and conditions, Body & MindTags: Cancer, Colorectal cancer, Tumor, Immunotherapy, Treatment, clinical trials

Who Voted for this Story



Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz




Add to Technorati Favorites
Username:

Password:

Remember: